Exhibit 99.1

1245 “Q” Street Lincoln, NE 68508 Phone: 402-475-2525 Fax: 402-475-9061

Contact: Kevin R. Karas Chief Financial Officer 402-475-2525

NATIONAL RESEARCH CORPORATION ANNOUNCES

SECOND QUARTER 2019 RESULTS

LINCOLN, Nebraska (August 6, 2019) — National Research Corporation (NASDAQ:NRC) today announced results for the second quarter of 2019.

● Net New Sales of $6.1 million up 14%

● Revenue increased 12% to $31.4 million

● Operating Income increased 31% to $10.1 million

● Voice of the Customer (VoC) platform revenue increased by 38%

Commenting on recent performance, Michael D. Hays, chief executive officer of National Research Corporation said, “The Company’s performance for the quarter was extremely strong and that momentum continues in the third quarter with the signing of the largest new client contract of the year.”

Revenue for the quarter ended June 30, 2019 was $31.4 million, compared to $28.0 million for the same quarter in 2018. Net income for the quarter ended June 30, 2019, was $7.4 million, compared to $7.9 million for the quarter ended June 30, 2018. Diluted earnings per share increased to $0.29 for the common stock (formerly Class A) for the quarter ended June 30, 2019, from diluted earnings per share of $0.28 for Class A shares and $0.26 for Class B shares for the quarter ended June 30, 2018. Due to the recapitalization transaction on April 17, 2018, income has been allocated to both classes of shares through April 16, 2018, and allocated only to common stock (formerly Class A) after April 16, 2018.

Regarding the Company’s second quarter financial performance, Kevin Karas, chief financial officer of National Research Corporation, said, “Our sales performance continues to gain momentum with our total net new sales for the trailing four quarters increasing by over 13% compared to the prior four quarters. The continued focus on adding new customers to the VoC platform solution and driving value for existing customers resulted in an increase in total contract value in the second quarter of 7% over the prior year and expansion of operating income margins to 33% on a year-to-date basis.”

NRC Announces Second Quarter 2019 Results

Page 2

August 6, 2019

A listen-only simulcast of National Research Corporation’s 2019 second quarter conference call will be available online at http://edge.media-server.com/mmc/p/vcr2isv8 on August 7, 2019, beginning at 11:00 a.m. Eastern time. The online replay will follow approximately one hour later and continue for 30 days.

For more than 38 years, National Research Corporation has been a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations in the United States and Canada. The Company’s solutions enable its clients to understand the voice of the customer with greater clarity, immediacy and depth.

This press release includes “forward-looking” statements related to the Company that can generally be identified as describing the Company’s future plans, objectives or goals. Such forward-looking statements are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the factors that could affect the Company’s future results, please see the Company’s filings with the Securities and Exchange Commission.

-END-

NRC Announces Second Quarter 2019 Results

Page 3

August 6, 2019

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

Unaudited Condensed Consolidated Statements of Income

(In thousands, except per share data)

	Three months ended June 30,						Six months ended June 30,
	2019			2018			2019			2018
Revenue	$	31,414		$	28,017		$	62,894		$	59,034
Operating expenses:
Direct expenses		11,506			10,996			23,160			23,160
Selling, general and administrative		8,319			7,940			16,026			15,808
Depreciation and amortization		1,440			1,325			2,855			2,608
Total operating expenses		21,265			20,261			42,041			42,320
Operating income		10,149			7,756			20,853			16,714
Other income (expense):
Interest income		8			9			14			54
Interest expense		(533	)		(439	)		(1,103	)		(447	)
Other, net		(139	)		493			(419	)		464
Total other income (expense)		(664	)		63			(1,508	)		71
Income before income taxes		9,485			7,819			19,345			16,785
Provision (benefit) for income taxes		2,092			(129	)		3,756			1,531
Net income	$	7,393		$	7,948		$	15,589		$	15,254
Earnings Per Share of Common Stock:
Basic Earnings Per Share:
Common (formerly Class A)	$	0.30		$	0.29		$	0.63		$	0.47
Class B	$	--		$	0.27		$	--		$	1.31
Diluted Earnings Per Share:
Common (formerly Class A)	$	0.29		$	0.28		$	0.61		$	0.45
Class B	$	--		$	0.26		$	--		$	1.27
Weighted average shares and share equivalents outstanding
Common (formerly Class A) - basic		24,789			23,957			24,777			22,429
Class B - basic		--			3,527			--			3,527
Common (formerly Class A) - diluted		25,586			24,846			25,549			23,350
Class B - diluted		--			3,620			--			3,628

-END- 

NRC Announces Second Quarter 2019 Results

Page 3

August 6, 2019

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

Unaudited Condensed Consolidated Balance Sheets

(Dollars in thousands, except per share amounts and par value)

	June 30, 2019			December 31, 2018
Assets
Current assets:
Cash and cash equivalents	$	4,020		$	12,991
Accounts receivable, net		15,087			11,922
Income taxes receivable		637			348
Other current assets		3,144			3,149
Total current assets		22,888			28,410
Net property and equipment		13,872			14,153
Goodwill		57,922			57,831
Other, net		9,593			7,638
Total assets	$	104,275		$	108,032
Liabilities and Shareholders’ Equity
Current liabilities:
Notes payable and line of credit	$	4,890		$	3,667
Accounts payable and accrued expenses		3,999			3,447
Accrued compensation		5,535			5,798
Income taxes payable		43			636
Dividends payable		4,727			17,113
Deferred revenue		16,988			16,244
Other current liabilities		894			204
Total current liabilities		37,076			47,109
Non-current liabilities		41,232			41,840
Total liabilities		78,308			88,949
Shareholders’ equity:
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued		--			--
Common stock, $0.001 par value; authorized 60,000,000 shares, issued 30,027,919 in 2019 and 29,917,667 in 2018, outstanding 24,879,414 in 2019 and 24,800,796 in 2018		30			30
Additional paid-in capital		158,691			157,312
Retained earnings (accumulated deficit)		(100,201	)		(106,339	)
Accumulated other comprehensive loss, foreign currency translation adjustment		(2,296	)		(2,916	)
Treasury stock		(30,257	)		(29,004	)
Total shareholders’ equity		25,967			19,083
Total liabilities and shareholders’ equity	$	104,275		$	108,032

-END-